Ozempic lot recall in Canada: separating fact from TikTok panic
Quick answer
Health Canada issued a Type 2 recall for Ozempic (semaglutide) 1mg prefilled pens, lot RZFFE55, due to reports of cracked cartridges that could cause medication leakage or inaccurate dosing. For patients with type 2 diabetes or those using semaglutide for weight management, inconsistent dosing can disrupt glycemic control and reduce therapeutic efficacy. Affected patients should return the product to their pharmacy and consult their prescriber before missing a scheduled injection.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @misterpharmacist actually say?
Alex, a Toronto-based pharmacist on TikTok, told his audience to check their fridges immediately for Ozempic 1mg lot number RZFFE55, citing a Health Canada Type 2 recall over cracked cartridges. He said cracked cartridges could cause "leaking meds or getting the wrong dose altogether" and directed viewers to return the affected lot to their pharmacy. He also clarified this applies to Canada only.
The core message was urgent but practical: identify the lot number on the box, return it, and spread the word. He did not recommend an alternative product, suggest a replacement dose, or make any therapeutic claims about semaglutide. For a health alert video aimed at a general audience, the scope was appropriately narrow.
One thing worth flagging immediately: he mispronounced the manufacturer as "Novor Nordus" instead of Novo Nordisk. Minor, but worth noting for credibility purposes.
Does the science back this up?
Yes, and this is not a borderline case. Health Canada issued a recall notice for Ozempic (semaglutide) 1mg prefilled pens, lot RZFFE55, manufactured by Novo Nordisk Canada. The recall is documented in Health Canada's public recall database and is classified as a Type 2 recall, meaning the product may cause temporary adverse health consequences but is unlikely to cause serious harm or death.
The concern about cracked cartridges is mechanically sound. Ozempic 1mg is delivered via a prefilled pen injector. A cracked cartridge in that system creates two documented risks: first, medication can leak out, reducing the actual dose delivered; second, air can enter the cartridge, further compromising dose accuracy. Both scenarios are clinically relevant for patients managing type 2 diabetes or using the medication for weight management, where consistent dosing directly affects glycemic control and treatment outcomes. The Diabetes Care literature has consistently documented that inconsistent GLP-1 receptor agonist dosing disrupts HbA1c reduction trajectories (Marso et al., 2016, New England Journal of Medicine).
What did they get wrong (or right)?
Alex got the big stuff right. The lot number, the recall classification, the mechanism of concern, and the recommended action are all accurate and consistent with Health Canada's public notice. That is not nothing. A lot of health TikTok traffic around recalls involves creators misquoting lot numbers, inflating the hazard level, or speculating about causes. He did none of that.
Where he slightly overstated things: he described a Type 2 recall as something that "can cause unwanted side effects." That framing is a bit loose. A Type 2 recall means Health Canada has determined the product is unlikely to cause serious harm, but the situation warrants action. Calling potential incorrect dosing merely "unwanted side effects" undersells the clinical stakes for a diabetic patient who might go underdosed for a week or more without realizing it. That said, he did not catastrophize, which is equally common in this genre of content.
The mispronunciation of Novo Nordisk as "Novor Nordus" is the kind of thing that erodes trust unnecessarily. If you are presenting yourself as a pharmacist and patient advocate, getting the manufacturer's name right matters.
What should you actually know?
If you are using Ozempic 1mg in Canada, check your pen or box for lot number RZFFE55. If you have it, stop using it and return it to the pharmacy where you filled the prescription. Do not attempt to inspect the cartridge yourself for cracks, as micro-fractures may not be visible to the naked eye.
Health Canada's Type 2 classification means this is a real but limited-scope concern. You are not being told the drug is contaminated or that semaglutide itself is unsafe. You are being told one specific lot had a manufacturing defect in the physical cartridge that could affect delivery accuracy.
Contact your pharmacist or prescribing physician before skipping your scheduled dose. Missing a GLP-1 receptor agonist injection without a clinical plan can affect your blood sugar management, and your care team can arrange a replacement supply. Health Canada's recall database at canada.ca is publicly searchable and is the definitive source for current recall status on this lot.
FormBlends bottom line
This video is a net positive for public health. Alex identified a real, documented recall, gave the correct lot number, explained the mechanism clearly enough for a lay audience, and told people what to do. The flaws are real but minor: a mispronounced manufacturer name and a slightly soft description of what a Type 2 recall means in clinical terms. For an 8,500-view TikTok on a patient safety topic, this clears a bar that much larger health accounts routinely fail to clear. Share it if you know someone on Ozempic in Canada.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Ozempic lot recall in Canada: separating fact from TikTok panic, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Claim verdict
The useful answer behind this video
Claim being checked
Health Canada issued a Type 2 recall for Ozempic (semaglutide) 1mg prefilled pens, lot RZFFE55, due to reports of cracked cartridges that could cause medication leakage or inaccurate dosing.
FormBlends verdict
Health Canada issued a Type 2 recall for Ozempic (semaglutide) 1mg prefilled pens, lot RZFFE55, due to reports of cracked cartridges that could cause medication leakage or inaccurate dosing. For patients with type 2 diabetes or those using semaglutide for weight management, inconsistent dosing can disrupt glycemic control and reduce therapeutic efficacy. Affected patients should return the product to their pharmacy and consult their prescriber before missing a scheduled injection.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Health Canada issued a Type 2 recall for Ozempic (semaglutide) 1mg prefilled pens, lot RZFFE55, due to reports of cracked cartridges that could cause medication leakage or inaccurate dosing. For patients with type 2 diabetes or those using semaglutide for weight management, inconsistent dosing can disrupt glycemic control and reduce therapeutic efficacy. Affected patients should return the product to their pharmacy and consult their prescriber before missing a scheduled injection.
- Health Canada confirmed a Type 2 recall of Ozempic 1mg, lot RZFFE55, due to cracked cartridge reports. Check canada.ca for current recall status.
- A Type 2 recall means Health Canada judges the product unlikely to cause serious or permanent harm, but action is still required from patients holding this lot.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- Health Canada confirmed a Type 2 recall of Ozempic 1mg, lot RZFFE55, due to cracked cartridge reports. Check canada.ca for current recall status.
- A Type 2 recall means Health Canada judges the product unlikely to cause serious or permanent harm, but action is still required from patients holding this lot.
- Cracked pen cartridges can allow medication to leak or air to enter, reducing the delivered dose. For GLP-1 therapy, dose accuracy directly affects HbA1c outcomes (Marso et al., 2016, NEJM).
- If you hold lot RZFFE55, stop using the pen and return it to the pharmacy. Do not skip your injection without contacting your prescriber first.
- The creator correctly identified the lot number, recall class, and recommended consumer action. Minor inaccuracies include mispronouncing Novo Nordisk and slightly understating what a Type 2 recall means clinically.
- This recall applies to Canada only. Patients outside Canada on Ozempic 1mg are not affected by this specific lot recall.
- No claims were made in this video about semaglutide curing disease, nor were unsafe dosing recommendations given. The video's scope was appropriate and largely factually sound.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
MisterPharmacist · TikTok creator
8.5K views on this video
If you're using Ozempic in Canada, stop what you're doing and check your fridge now! Novo Nordisk Canada has recalled Lot RZFFE55 of Ozempic 1mg due to cracked cartridges, which could lead to medication leakage or incorrect dosing. This isn't just a minor issue—it's a type two health hazard recall. Don't use this lot, as it could subject you to unwanted side effects. Look at the box's side for Lot RZFFE55, return it to your pharmacy if found, and inform anyone else who might be affected. Act sma
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by MisterPharmacist, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.